Home
About
Corporate Mission
Leadership
Advisors
Technology
Platform
Product
Pipeline
Overview
Preclinical Data
Clinical Data
Investors
Investor Relations
IR Overview
News / Events
Press Releases
IR Calendar
Presentations
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Governance Documents
Contact
Home
Investors
News / Events
Press Releases
Investors
Overview
News / Events
Press Releases
IR Calendar
Presentations
Stock Data
SEC Filings
Corporate Governance
Press Releases
All News
By Year:
2018
2017
2016
2015
2014
2013
04/5/16
Arch Therapeutics Announces Notice of Allowance for Composition-of-Matter Patent Covering Self-Assembling Peptides
03/22/16
Arch Therapeutics Obtains Favorable Safety Data for AC5 Surgical Hemostatic Device(TM) in Skin Irritation Testing in Humans
03/14/16
Arch Therapeutics Reports Favorable Results for AC5 Surgical Hemostatic Device in Biocompatibility Testing Required for CE Mark
03/10/16
Arch Therapeutics to Present at the 28th Annual Roth Capital Conference on Tuesday, March 15, 2016
03/9/16
Arch Therapeutics Receives ISO 13485 Certification for AC5
03/7/16
Arch Therapeutics Clinical Trial Actively Enrolling Patients and Providing Investigational Treatment
02/17/16
Arch Therapeutics to Present at the SeeThruEquity Annual Innovations Investor Conference in Miami, Florida on Monday, February 22, 2016
02/8/16
Arch Therapeutics to Present at the Source Capital Group's 2016 Disruptive Growth & Healthcare Conference on Wednesday, February 10, 2016
02/3/16
Arch Therapeutics to Present at the BIO CEO & Investor Conference on Monday, February 8, 2016
01/4/16
Arch Therapeutics to Present at the Biotech Showcase(TM) 2016 Conference on January 12th 2016
<< Previous
1
2
3
4
5
6
Show All
